Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of TissueGene-C in knee osteoarthritis
KCT0001112Phase 3Active, not recruiting
- Sponsor
- Kolon Life Science Inc.
- Start
- Nov 2013
- Modality
- Cell Therapies, Gene Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Invossa in knee osteoarthritis (OA), sponsored by Kolon Life Science Inc.. Started Nov 2013; status: active, not recruiting.
02
Drugs
Invossa
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0001112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001112.